课题基金 / 基金详情

PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL

PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
第 3 阶段研究：低级别淋巴组合物环磷酰胺/氟达拉滨至 STD THER FOL
批准号：
7625854
负责人：
CHRISTOPHER EHMANN
金额：
$0.22万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-04-01 至 2008-03-31
来源：
https://reporter.nih.gov/project-details/7625854
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseCyclophosphamide/FludarabineFundingGrantInstitutionLymphLymphocyteLymphomaMaintenanceNumbersPatientsPhase III Clinical TrialsPurposeRateResearchResearch PersonnelResourcesSourceStandards of Weights and MeasuresTimeTreatment ProtocolsUnited States National Institutes of HealthUpper armresponse

项目摘要

项目成果

CHRISTOPHER EHMANN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to compare the response rate, time to progression and survival for patients with low-grade lymphoma treated with the Cyclophosphamide/Fludarabine regimen with a control arm of standard CVP. The study will also determine the effect of maintenance with anti-CD20 on time to progression and survival and its effect on lymphocytic number, subsets and quantitative immunoglobin levels over time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YR
CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE
CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE
P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YRS OF ADJ TAMOXIF
海外基金